DASATINIB | DASATINIB | ATC L01EA02
ANTINEOPLASTIC PROTEIN KINASE INHIBITORS TREATMENT OF CHRONIC MYELOID LEUKEMIA (CML) IN CHRONIC PHASE | ORAL | VD 2505 LITER PPB 96 PERCENT Cl 433 LITER / HOUR (EQN) HT 4 HOUR SOLUBILITY INSOLUBLE IN WATER | BCR-ABL ABL1 SRC FAMILY (SRC, LCK, YES, FYN) C-KIT EPHA2 PDGFR BETA PDB 2Y6O (CRYSTAL STRUCTURE OF EPHA4 KINASE DOMAIN IN COMPLEX WITH DASATINIB.) LIGAND CODE = 1N1 (link to the list of PDB complexes) Download experimental 3D coordinates of 1N1 with added hydrogens | Platelet-derived growth factor receptor beta UNIPROT P09619 PDGFRB -- Tyrosine-protein kinase ABL1 UNIPROT P00519 ABL1 more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |